Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients With Treatment Resistant Depression: A Double Blind Placebo Controlled Trial


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02522377

Organisation Name: The Cleveland Clinic

Overal Status: Completed

Start Date: August 2015

Last Update: August 29, 2019

Lead Sponsor: The Cleveland Clinic

Brief Summary: In this proof of concept study, the investigators plan to administer iv ketamine interleaved with ECT days.

Patients with treatment resistant depression who are deemed to be eligible for ECT treatment will randomly be assigned to either ketamine or active placebo.

Conditions:
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Severe Depression


Total execution time in seconds: 0.57065010070801